CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+1.91%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.7B
AUM Growth
+$14.7B
(+0.67%)
Cap. Flow
+$182M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
956
New
63
Increased
335
Reduced
301
Closed
69
Top Buys
| 1 |
NVIDIA
NVDA
|
$92M |
| 2 |
Johnson & Johnson
JNJ
|
$54.5M |
| 3 |
AstraZeneca
AZN
|
$46.3M |
| 4 |
Autodesk
ADSK
|
$40.5M |
| 5 |
Mercado Libre
MELI
|
$39.4M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$92.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$85.8M |
| 3 |
GE Aerospace
GE
|
$62.1M |
| 4 |
Alibaba
BABA
|
$60.1M |
| 5 |
Merck
MRK
|
$49.2M |
Sector Composition
| 1 | Healthcare | 32.1% |
| 2 | Technology | 24.54% |
| 3 | Financials | 9.08% |
| 4 | Communication Services | 8.24% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Kymera Therapeutics
KYMR
$2.99B
| $23.2M | 0.16% |
394,991
-16,000
| -4% | -$940K |
|
152
Enphase Energy
ENPH
$4.88B
| $23.2M | 0.16% |
154,511
+2,581
| +2% | +$387K |
|
153
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.44B
| $22.9M | 0.16% |
427,769
+10,298
| +2% | +$551K |
|
154
West Pharmaceutical
WST
$17.5B
| $22.9M | 0.16% |
53,868
-14,891
| -22% | -$6.32M |
|
155
Bristol-Myers Squibb
BMY
$96.6B
| $22.5M | 0.15% |
380,950
-18,433
| -5% | -$1.09M |
|
156
Exxon Mobil
XOM
$479B
| $22.3M | 0.15% |
379,626
+8,529
| +2% | +$502K |
|
157
Chipotle Mexican Grill
CMG
$56B
| $22.2M | 0.15% |
12,230
-6,308
| -34% | -$11.5M |
|
158
Netflix
NFLX
$516B
| $22.1M | 0.15% |
36,162
-7,184
| -17% | -$4.38M |
|
159
Exact Sciences
EXAS
$9.2B
| $22M | 0.15% |
230,859
-8,133
| -3% | -$776K |
|
160
Cerence
CRNC
$422M
| $21.9M | 0.15% |
227,528
+46,928
| +26% | +$4.51M |
|
161
McCormick & Company Non-Voting
MKC
$18.4B
| $21.8M | 0.15% |
269,301
+138,296
| +106% | +$11.2M |
|
162
Ameresco
AMRC
$1.35B
| $21.8M | 0.15% |
372,639
+5,133
| +1% | +$300K |
|
163
Hilton Worldwide
HLT
$64.8B
| $21.5M | 0.15% |
155,382
-1,006
| -0.6% | -$139K |
|
164
Aflac
AFL
$56.5B
| $21.4M | 0.15% |
409,739
+350,534
| +592% | +$18.3M |
|
165
BioMarin Pharmaceuticals
BMRN
$11.2B
| $21.3M | 0.15% |
276,207
+168,364
| +156% | +$13M |
|
166
BridgeBio Pharma
BBIO
$9.88B
| $21.3M | 0.15% |
455,285
| – | – |
|
167
lululemon athletica
LULU
$23.8B
| $21.3M | 0.15% |
52,693
+2,380
| +5% | +$963K |
|
168
Elevance Health
ELV
$71.8B
| $21M | 0.14% |
56,350
-501
| -0.9% | -$187K |
|
169
Iovance Biotherapeutics
IOVA
$792M
| $20.9M | 0.14% |
848,652
-171,774
| -17% | -$4.24M |
|
170
Ally Financial
ALLY
$12.5B
| $20.9M | 0.14% |
380,571
+47,284
| +14% | +$2.59M |
|
171
Xencor
XNCR
$581M
| $20.8M | 0.14% |
637,800
+133,256
| +26% | +$4.35M |
|
172
Shopify
SHOP
$182B
| $20.8M | 0.14% |
15,312
+13,309
| +664% | +$18.1M |
|
|
Y
173
DELISTED
Alleghany Corporation
Y
| $20.4M | 0.14% |
32,698
+7,616
| +30% | +$4.76M |
|
174
Trex
TREX
$6.38B
| $20.3M | 0.14% |
198,732
+28,825
| +17% | +$2.94M |
|
|
TRIL
175
DELISTED
Trillium Therapeutics Inc.
TRIL
| $20.2M | 0.14% |
1,150,280
+360,182
| +46% | +$6.32M |
|